Incorporation of radioactive orotic acid and 8-azaguanine into rat liver RNA.

G. Pfeifer,O. E. Michaelis,B. Szepesi

1974-12-01

Abstract:

What problem does this paper attempt to address?

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

Kun Zhou,Sirong Piao,Xiao Liu,Xiao Luo,Hongyi Chen,Rui Xiang,Daoying Geng

DOI: https://doi.org/10.3389/fnagi.2022.1073909

IF: 4.8

2023-01-01

Frontiers in Aging Neuroscience

Abstract:IntroductionAlzheimer’s disease (AD) is a progressive and irreversible brain degenerative disorder early. Among all diagnostic strategies, hippocampal atrophy is considered a promising diagnostic method. In order to proactively detect patients with early Alzheimer’s disease, we built an Alzheimer’s segmentation and classification (AL-SCF) pipeline based on machine learning.MethodsIn our study, we collected coronal T1 weighted images that include 187 patients with AD and 230 normal controls (NCs). Our pipeline began with the segmentation of the hippocampus by using a modified U2-net. Subsequently, we extracted 851 radiomics features and selected 37 features most relevant to AD by the Hierarchical clustering method and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm. At last, four classifiers were implemented to distinguish AD from NCs, and the performance of the models was evaluated by accuracy, specificity, sensitivity, and area under the curve.ResultsOur proposed pipeline showed excellent discriminative performance of classification with AD vs NC in the training set (AUC=0.97, 95% CI: (0.96-0.98)). The model was also verified in the validation set with Dice=0.93 for segmentation and accuracy=0.95 for classification.DiscussionThe AL-SCF pipeline can automate the process from segmentation to classification, which may assist doctors with AD diagnosis and develop individualized medical plans for AD in clinical practice.
Exploration of Imaging Genetic Biomarkers of Alzheimer's Disease Based on a Machine Learning Method

Yuanfei Wang,Xitao Wang

DOI: https://doi.org/10.31083/j.jin2304081

2024-04-17

Abstract:Background: Alzheimer's disease (AD) is an irreversible primary brain disease with insidious onset. The rise of imaging genetics research has led numerous researchers to examine the complex association between genes and brain phenotypes from the perspective of computational biology. Methods: Given that most previous studies have assumed that imaging data and genetic data are linearly related and are therefore unable to explore their nonlinear relationship, our study applied a joint depth semi-supervised nonnegative matrix decomposition (JDSNMF) algorithm to solve this problem. The JDSNMF algorithm jointly decomposed multimodal imaging genetics data into both a standard basis matrix and multiple feature matrices. During the decomposition process, the coefficient matrix A multilayer nonlinear transformation was performed using a neural network to capture nonlinear features. Results: The results using a real dataset demonstrated that the algorithm can fully exploit the association between strongly correlated image genetics data and effectively detect biomarkers of AD. Our results might provide a reference for identifying biologically significant imaging genetic correlations, and help to elucidate disease-related mechanisms. Conclusions: The diagnostic model constructed by the top features of the three modality data sets mined by the algorithm has high accuracy, and these features are expected to become new therapeutic targets for AD.
A Novel Longitudinal Phenotype-Genotype Association Study Based on Deep Feature Extraction and Hypergraph Models for Alzheimer's Disease

Wei Kong,Yufang Xu,Shuaiqun Wang,Kai Wei,Gen Wen,Yaling Yu,Yuemin Zhu

DOI: https://doi.org/10.3390/biom13050728

IF: 6.064

2023-04-23

Biomolecules

Abstract:Traditional image genetics primarily uses linear models to investigate the relationship between brain image data and genetic data for Alzheimer's disease (AD) and does not take into account the dynamic changes in brain phenotype and connectivity data across time between different brain areas. In this work, we proposed a novel method that combined Deep Subspace reconstruction with Hypergraph-Based Temporally-constrained Group Sparse Canonical Correlation Analysis (DS-HBTGSCCA) to discover the deep association between longitudinal phenotypes and genotypes. The proposed method made full use of dynamic high-order correlation between brain regions. In this method, the deep subspace reconstruction technique was applied to retrieve the nonlinear properties of the original data, and hypergraphs were used to mine the high-order correlation between two types of rebuilt data. The molecular biological analysis of the experimental findings demonstrated that our algorithm was capable of extracting more valuable time series correlation from the real data obtained by the AD neuroimaging program and finding AD biomarkers across multiple time points. Additionally, we used regression analysis to verify the close relationship between the extracted top brain areas and top genes and found the deep subspace reconstruction approach with a multi-layer neural network was helpful in enhancing clustering performance.
[Uterine rupture due to unrecognized uterine scarring].

P. Meicler,E. Darai,C. Pinet,I. Raoust,J. Colau

1991-10-01

Abstract:Uterine rupture affecting the pregnant uterus has become rare. It occurs essentially in the presence of scarring. The cases reported here described rupture following evacuation curettage which had caused an unrecognized uterine perforation. While such perforations often have no serious consequences, this explaining the usual abstention from treatment, it is nevertheless important that acute complications (intestinal or vascular trauma) or long term (uterine rupture of pregnant uterus) should not pass unrecognized.
Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer's Disease

Dengdeng Yu,Linbo Wang,Dehan Kong,Hongtu Zhu

DOI: https://doi.org/10.1080/01621459.2022.2087658

IF: 4.369

2022-07-21

Journal of the American Statistical Association

Abstract:Alzheimer's disease is a progressive form of dementia that results in problems with memory, thinking, and behavior. It often starts with abnormal aggregation and deposition of β amyloid and tau, followed by neuronal damage such as atrophy of the hippocampi, leading to Alzheimer's disease (AD). The aim of this article is to map the genetic-imaging-clinical pathway for AD in order to delineate the genetically-regulated brain changes that drive disease progression based on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. We develop a novel two-step approach to delineate the association between high-dimensional 2D hippocampal surface exposures and the Alzheimer's Disease Assessment Scale (ADAS) cognitive score, while taking into account the ultra-high dimensional clinical and genetic covariates at baseline. Analysis results suggest that the radial distance of each pixel of both hippocampi is negatively associated with the severity of behavioral deficits conditional on observed clinical and genetic covariates. These associations are stronger in Cornu Ammonis region 1 (CA1) and subiculum subregions compared to Cornu Ammonis region 2 (CA2) and Cornu Ammonis region 3 (CA3) subregions. Supplementary materials for this article, including a standardized description of the materials available for reproducing the work, are available as an online supplement.

statistics & probability
Feature Detection Based on Imaging and Genetic Data Using Multi-Kernel Support Vector Machine–Apriori Model

Zhixi Hu,Congye Tang,Yingxia Liang,Senhao Chang,Xinyue Ni,Shasha Xiao,Xianglian Meng,Bing He,Wenjie Liu

DOI: https://doi.org/10.3390/math12050684

IF: 2.4

2024-02-27

Mathematics

Abstract:Alzheimer's disease (AD) is a significant neurological disorder characterized by progressive cognitive decline and memory loss. One essential task is understanding the molecular mechanisms underlying brain disorders of AD. Detecting biomarkers that contribute significantly to the classification of AD is an effective means to accomplish this essential task. However, most machine learning methods used to detect AD biomarkers require lengthy training and are unable to rapidly and effectively detect AD biomarkers. To detect biomarkers for AD accurately and efficiently, we proposed a novel approach using the Multi-Kernel Support Vector Machine (SVM) with Apriori algorithm to mine strongly associated feature sets from functional magnetic resonance imaging (fMRI) and gene expression profiles. Firstly, we downloaded the imaging data and genetic data of 121 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and transformed gene sequences into labeled sequences by encoding the four types of bases (A, T, C, and G) into distinct labels. Subsequently, we extracted the first 130 temporal sequences of brain regions and employed Pearson correlation analysis to construct "brain region gene pairs". The integration of these data allowed us to explore the correlations between genes and brain regions. To improve classification accuracy and feature selection, we applied the Apriori algorithm to the multi-kernel SVM, dynamically building feature combinations and continuously validating classification results. By iteratively generating frequent itemsets, we obtained important brain region gene pairs. Experimental results show the effectiveness of our proposed approach. The Multi-Kernel SVM with Apriori model achieves an accuracy of 92.9%, precision of 95%, and an F1 score of 95% in classifying brain region-gene pairs within the AD–Late mild cognitive impairment (AD-LMCI) group. The amygdala, BIN1, RPN2, and IL15 associated with AD have been identified and demonstrate potential in identifying potential pathogenic factors of AD. The selected brain regions and associated genes may serve as valuable biomarkers for early AD diagnosis and better understanding of the disease's molecular mechanisms. The integration of fMRI and gene data using the Multi-Kernel SVM–Apriori model holds great potential for advancing our knowledge of brain function and the genetic basis of neurological disorders. This approach provides a valuable tool for neuroscientists and researchers in the field of genomics and brain imaging studies.

mathematics
Mining High-Level Imaging Genetic Associations via Clustering AD Candidate Variants with Similar Brain Association Patterns

Ruiming Wu,Jingxuan Bao,Mansu Kim,Andrew J. Saykin,Jason H. Moore,Li Shen,on behalf of ADNI

DOI: https://doi.org/10.3390/genes13091520

IF: 4.141

2022-08-25

Genes

Abstract:Brain imaging genetics examines associations between imaging quantitative traits (QTs) and genetic factors such as single nucleotide polymorphisms (SNPs) to provide important insights into the pathogenesis of Alzheimer's disease (AD). The individual level SNP-QT signals are high dimensional and typically have small effect sizes, making them hard to be detected and replicated. To overcome this limitation, this work proposes a new approach that identifies high-level imaging genetic associations through applying multigraph clustering to the SNP-QT association maps. Given an SNP set and a brain QT set, the association between each SNP and each QT is evaluated using a linear regression model. Based on the resulting SNP-QT association map, five SNP–SNP similarity networks (or graphs) are created using five different scoring functions, respectively. Multigraph clustering is applied to these networks to identify SNP clusters with similar association patterns with all the brain QTs. After that, functional annotation is performed for each identified SNP cluster and its corresponding brain association pattern. We applied this pipeline to an AD imaging genetic study, which yielded promising results. For example, in an association study between 54 AD SNPs and 116 amyloid QTs, we identified two SNP clusters with one responsible for amyloid beta clearances and the other regulating amyloid beta formation. These high-level findings have the potential to provide valuable insights into relevant genetic pathways and brain circuits, which can help form new hypotheses for more detailed imaging and genetics studies in independent cohorts.

genetics & heredity
Multi-Modal Data Analysis for Alzheimer’s Disease Diagnosis: An Ensemble Model Using Imagery and Genetic Features

Qi Ying,Xin Xing,Liangliang Liu,Ai-Ling Lin,Nathan Jacobs,Gongbo Liang

DOI: https://doi.org/10.1101/2021.05.07.443184

2021-05-09

Abstract:Abstract Alzheimer’s disease (AD) is a devastating neurological disorder primarily affecting the elderly. An estimated 6.2 million Americans age 65 and older are suffering from Alzheimer’s dementia today. Brain magnetic resonance imaging (MRI) is widely used for the clinical diagnosis of AD. In the meanwhile, medical researchers have identified 40 risk locus using single-nucleotide polymorphisms (SNPs) information from Genome-wide association study (GWAS) in the past decades. However, existing studies usually treat MRI and GWAS separately. For instance, convolutional neural networks are often trained using MRI for AD diagnosis. GWAS and SNPs are frequently used to identify genomic traits. In this study, we propose a multi-modal AD diagnosis neural network that uses both MRIs and SNPs. The proposed method demonstrates a novel way to use GWAS findings by directly including SNPs in predictive models. We test the proposed methods on the Alzheimer’s Disease Neuroimaging Initiative dataset. The evaluation results show that the proposed method improves the model performance on AD diagnosis and achieves 93.5% AUC and 96.1% AP, respectively, when patients have both MRI and SNP data. We believe this work brings exciting new insights to GWAS applications and sheds light on future research directions.
Integrating omics and MRI data with kernel-based tests and CNNs to identify rare genetic markers for Alzheimer's disease

Stefan Konigorski,Shahryar Khorasani,Christoph Lippert

DOI: https://doi.org/10.48550/arXiv.1812.00448

2019-03-06

Abstract:For precision medicine and personalized treatment, we need to identify predictive markers of disease. We focus on Alzheimer's disease (AD), where magnetic resonance imaging scans provide information about the disease status. By combining imaging with genome sequencing, we aim at identifying rare genetic markers associated with quantitative traits predicted from convolutional neural networks (CNNs), which traditionally have been derived manually by experts. Kernel-based tests are a powerful tool for associating sets of genetic variants, but how to optimally model rare genetic variants is still an open research question. We propose a generalized set of kernels that incorporate prior information from various annotations and multi-omics data. In the analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), we evaluate whether (i) CNNs yield precise and reliable brain traits, and (ii) the novel kernel-based tests can help to identify loci associated with AD. The results indicate that CNNs provide a fast, scalable and precise tool to derive quantitative AD traits and that new kernels integrating domain knowledge can yield higher power in association tests of very rare variants.

Machine Learning,Genomics
Integration of Imaging Genomics Data for the Study of Alzheimer's Disease Using Joint-Connectivity-Based Sparse Nonnegative Matrix Factorization

Kai Wei,Wei Kong,Shuaiqun Wang

DOI: https://doi.org/10.1007/s12031-021-01888-6

Abstract:Imaging genetics reveals the connection between microscopic genetics and macroscopic imaging, enabling the identification of disease biomarkers. In this work, we make full use of prior knowledge that has significant reference value for investigating the correlation between the brain and genetics to explore more biologically substantial biomarkers. In this paper, we propose joint-connectivity-based sparse nonnegative matrix factorization (JCB-SNMF). The algorithm simultaneously projects structural magnetic resonance imaging (sMRI), single-nucleotide polymorphism sites (SNPs), and gene expression data onto a common feature space, where heterogeneous variables with large coefficients in the same projection direction form a common module. In addition, the connectivity information for each region of the brain and genetic data are added as prior knowledge to identify regions of interest (ROIs), SNPs, and gene-related risks related to Alzheimer's disease (AD) patients. GraphNet regularization increases the anti-noise performance of the algorithm and the biological interpretability of the results. The simulation results show that compared with other NMF-based algorithms (JNMF, JSNMNMF), JCB-SNMF has better anti-noise performance and can identify and predict biomarkers closely related to AD from significant modules. By constructing a protein-protein interaction (PPI) network, we identified SF3B1, RPS20, and RBM14 as potential biomarkers of AD. We also found some significant SNP-ROI and gene-ROI pairs. Among them, two SNPs rs4472239 and rs11918049 and three genes KLHL8, ZC3H11A, and OSGEPL1 may have effects on the gray matter volume of multiple brain regions. This model provides a new way to further integrate multimodal impact genetic data to identify complex disease association patterns.
Deep Feature Selection and Causal Analysis of Alzheimer's Disease

Yuanyuan Liu,Zhouxuan Li,Qiyang Ge,Nan Lin,Momiao Xiong

DOI: https://doi.org/10.3389/fnins.2019.01198

2019-11-15

Abstract:Deep convolutional neural networks (DCNNs) have achieved great success for image classification in medical research. Deep learning with brain imaging is the imaging method of choice for the diagnosis and prediction of Alzheimer's disease (AD). However, it is also well known that DCNNs are "black boxes" owing to their low interpretability to humans. The lack of transparency of deep learning compromises its application to the prediction and mechanism investigation in AD. To overcome this limitation, we develop a novel general framework that integrates deep leaning, feature selection, causal inference, and genetic-imaging data analysis for predicting and understanding AD. The proposed algorithm not only improves the prediction accuracy but also identifies the brain regions underlying the development of AD and causal paths from genetic variants to AD via image mediation. The proposed algorithm is applied to the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset with diffusion tensor imaging (DTI) in 151 subjects (51 AD and 100 non-AD) who were measured at four time points of baseline, 6 months, 12 months, and 24 months. The algorithm identified brain regions underlying AD consisting of the temporal lobes (including the hippocampus) and the ventricular system.
Multi-modal imaging genetics data fusion by deep auto-encoder and self-representation network for Alzheimer's disease diagnosis and biomarkers extraction

Cui-Na Jiao,Ying-Lian Gao,Dao-Hui Ge,Junliang Shang,Jin-Xing Liu

DOI: https://doi.org/10.1016/j.engappai.2023.107782

IF: 8

2024-01-05

Engineering Applications of Artificial Intelligence

Abstract:Alzheimer's disease (AD) is an incurable neurodegenerative disease, so it is important to intervene in the early stage of the disease. Brain imaging genetics is an effective technique to identify AD-related biomarkers, which can early diagnosis of AD patients once they are clinically verified. With the development of medical imaging and gene sequencing techniques, the association analysis between multi-modal imaging data and genetic data has garnered increasing attention. However, current imaging genetics studies have problem with non-intuitive data fusion. Meanwhile, the characteristics of multi-modal imaging genetics data are high-dimensional, non-linearity, and fewer subjects, so it is necessary to select effective features. In this paper, a multi-modal data fusion framework by deep auto-encoder and self-representation (MFASN) was proposed for early diagnosis of AD. First, a multi-modality brain network was constructed by combining information from the resting-state functional magnetic resonance imaging (fMRI) data and structural magnetic resonance imaging (sMRI) data. Then, we utilized the deep auto-encoder to achieve non-linear transformations and select the informative features. A sparse self-representation module was employed to capture the multi-subspaces structure of the latent representation. At last, a multi-task structured sparse association model was developed to fully mine correlations between the genetic data and multi-modal brain network features. Experiments on AD neuroimaging initiative datasets proved the superiority of the proposed method, while discovering discriminative biomarkers were strongly associated with AD.

automation & control systems,computer science, artificial intelligence,engineering, electrical & electronic, multidisciplinary
Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease

Xiaoke Hao,Xiaohui Yao,Jingwen Yan,Shannon L Risacher,Andrew J Saykin,Daoqiang Zhang,Li Shen,Alzheimer’s Disease Neuroimaging Initiative

DOI: https://doi.org/10.1007/s12021-016-9307-8

IF: 2.864

Neuroinformatics

Abstract:Neuroimaging genetics has attracted growing attention and interest, which is thought to be a powerful strategy to examine the influence of genetic variants (i.e., single nucleotide polymorphisms (SNPs)) on structures or functions of human brain. In recent studies, univariate or multivariate regression analysis methods are typically used to capture the effective associations between genetic variants and quantitative traits (QTs) such as brain imaging phenotypes. The identified imaging QTs, although associated with certain genetic markers, may not be all disease specific. A useful, but underexplored, scenario could be to discover only those QTs associated with both genetic markers and disease status for revealing the chain from genotype to phenotype to symptom. In addition, multimodal brain imaging phenotypes are extracted from different perspectives and imaging markers consistently showing up in multimodalities may provide more insights for mechanistic understanding of diseases (i.e., Alzheimer's disease (AD)). In this work, we propose a general framework to exploit multi-modal brain imaging phenotypes as intermediate traits that bridge genetic risk factors and multi-class disease status. We applied our proposed method to explore the relation between the well-known AD risk SNP APOE rs429358 and three baseline brain imaging modalities (i.e., structural magnetic resonance imaging (MRI), fluorodeoxyglucose positron emission tomography (FDG-PET) and F-18 florbetapir PET scans amyloid imaging (AV45)) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. The empirical results demonstrate that our proposed method not only helps improve the performances of imaging genetic associations, but also discovers robust and consistent regions of interests (ROIs) across multi-modalities to guide the disease-induced interpretation.
A blueprint for hospitals in an aging society. Part 3: Creating the organizational backdrop for effective services.

K. Dychtwald,M. Zitter

Abstract:
Integrating Genetic Information for Early Alzheimer’s Diagnosis through MRI Interpretation

Moonhyun Lee,Kyungtae Kang,Seungeun Lee,Jaeyoung Lee,Younghoon Kim,Jintak Choi

DOI: https://doi.org/10.1109/BHI58575.2023.10313442

2023-10-15

Abstract:Early detection of Alzheimer’s disease (AD) is crucial, yet predicting AD in the mild cognitive impairment stage remains challenging. Integrating biological data from genomics and neuroimaging can provide valuable insights into early detection and treatment. Although recent deep learning studies have shown promise in AD prediction tasks, they often lack the interpretation of multimodal data interactions. Therefore, there is a need for further research on deep learning methods that can effectively integrate and interpret multimodal biological data for AD diagnosis and prediction. This study proposes a novel approach for identifying regions where interactions occur in sMRI (structural MRI) and genetic information and for detecting discriminative features in AD progression. Through the use of an attention mechanism and contrastive loss, it effectively models the inter-relationships between these modalities, leading to a more accurate understanding of AD. Our proposed method achieved remarkable performance, with an accuracy of 92%. Additionally, through model interpretation, we were able to identify genetic and brain feature associations in AD progression. This integrating study provides an effective and interpretable approach for AD diagnosis and prediction.

Medicine,Computer Science
Detection of Association Features Based on Gene Eigenvalues and MRI Imaging Using Genetic Weighted Random Forest

Zhixi Hu,Xuanyan Wang,Li Meng,Wenjie Liu,Feng Wu,Xianglian Meng

DOI: https://doi.org/10.3390/genes13122344

IF: 4.141

2022-12-13

Genes

Abstract:In the studies of Alzheimer's disease (AD), jointly analyzing imaging data and genetic data provides an effective method to explore the potential biomarkers of AD. AD can be separated into healthy controls (HC), early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI) and AD. In the meantime, identifying the important biomarkers of AD progression, and analyzing these biomarkers in AD provide valuable insights into understanding the mechanism of AD. In this paper, we present a novel data fusion method and a genetic weighted random forest method to mine important features. Specifically, we amplify the difference among AD, LMCI, EMCI and HC by introducing eigenvalues calculated from the gene p-value matrix for feature fusion. Furthermore, we construct the genetic weighted random forest using the resulting fused features. Genetic evolution is used to increase the diversity among decision trees and the decision trees generated are weighted by weights. After training, the genetic weighted random forest is analyzed further to detect the significant fused features. The validation experiments highlight the performance and generalization of our proposed model. We analyze the biological significance of the results and identify some significant genes (CSMD1, CDH13, PTPRD, MACROD2 and WWOX). Furthermore, the calcium signaling pathway, arrhythmogenic right ventricular cardiomyopathy and the glutamatergic synapse pathway were identified. The investigational findings demonstrate that our proposed model presents an accurate and efficient approach to identifying significant biomarkers in AD.

genetics & heredity
Generalizable, Reproducible, and Neuroscientifically Interpretable Imaging Biomarkers for Alzheimer's Disease

Dan Jin,Bo Zhou,Ying Han,Jiaji Ren,Tong Han,Bing Liu,Jie Lu,Chengyuan Song,Pan Wang,Dawei Wang,Jian Xu,Zhengyi Yang,Hongxiang Yao,Chunshui Yu,Kun Zhao,Max Wintermark,Nianming Zuo,Xinqing Zhang,Yuying Zhou,Xi Zhang,Tianzi Jiang,Qing Wang,Yong Liu

DOI: https://doi.org/10.1002/advs.202000675

2020-01-01

Abstract:Precision medicine for Alzheimer's disease (AD) necessitates the development of personalized, reproducible, and neuroscientifically interpretable biomarkers, yet despite remarkable advances, few such biomarkers are available. Also, a comprehensive evaluation of the neurobiological basis and generalizability of the end-to-end machine learning system should be given the highest priority. For this reason, a deep learning model (3D attention network, 3DAN) that can simultaneously capture candidate imaging biomarkers with an attention mechanism module and advance the diagnosis of AD based on structural magnetic resonance imaging is proposed. The generalizability and reproducibility are evaluated using cross-validation on in-house, multicenter (n = 716), and public (n = 1116) databases with an accuracy up to 92%. Significant associations between the classification output and clinical characteristics of AD and mild cognitive impairment (MCI, a middle stage of dementia) groups provide solid neurobiological support for the 3DAN model. The effectiveness of the 3DAN model is further validated by its good performance in predicting the MCI subjects who progress to AD with an accuracy of 72%. Collectively, the findings highlight the potential for structural brain imaging to provide a generalizable, and neuroscientifically interpretable imaging biomarker that can support clinicians in the early diagnosis of AD.
Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer's disease continuum

Junhao Wen,Zhijian Yang,Ilya M. Nasrallah,Yuhan Cui,Guray Erus,Dhivya Srinivasan,Ahmed Abdulkadir,Elizabeth Mamourian,Gyujoon Hwang,Ashish Singh,Mark Bergman,Jingxuan Bao,Erdem Varol,Zhen Zhou,Aleix Boquet-Pujadas,Jiong Chen,Arthur W. Toga,Andrew J. Saykin,Timothy J. Hohman,Paul M. Thompson,Sylvia Villeneuve,Randy Gollub,Aristeidis Sotiras,Katharina Wittfeld,Hans J. Grabe,Duygu Tosun,Murat Bilgel,Yang An,Daniel S. Marcus,Pamela LaMontagne,Tammie L. Benzinger,Susan R. Heckbert,Thomas R. Austin,Lenore J. Launer,Mark Espeland,Colin L. Masters,Paul Maruff,Jurgen Fripp,Sterling C. Johnson,John C. Morris,Marilyn S. Albert,R. Nick Bryan,Susan M. Resnick,Luigi Ferrucci,Yong Fan,Mohamad Habes,David Wolk,Li Shen,Haochang Shou,Christos Davatzikos

DOI: https://doi.org/10.1038/s41398-024-03121-5

2024-10-06

Translational Psychiatry

Abstract:Alzheimer's disease (AD) is associated with heterogeneous atrophy patterns. We employed a semi-supervised representation learning technique known as Surreal-GAN, through which we identified two latent dimensional representations of brain atrophy in symptomatic mild cognitive impairment (MCI) and AD patients: the "diffuse-AD" (R1) dimension shows widespread brain atrophy, and the "MTL-AD" (R2) dimension displays focal medial temporal lobe (MTL) atrophy. Critically, only R2 was associated with widely known sporadic AD genetic risk factors (e.g., APOE ε4 ) in MCI and AD patients at baseline. We then independently detected the presence of the two dimensions in the early stages by deploying the trained model in the general population and two cognitively unimpaired cohorts of asymptomatic participants. In the general population, genome-wide association studies found 77 genes unrelated to APOE differentially associated with R1 and R2. Functional analyses revealed that these genes were overrepresented in differentially expressed gene sets in organs beyond the brain (R1 and R2), including the heart (R1) and the pituitary gland, muscle, and kidney (R2). These genes were enriched in biological pathways implicated in dendritic cells (R2), macrophage functions (R1), and cancer (R1 and R2). Several of them were "druggable genes" for cancer (R1), inflammation (R1), cardiovascular diseases (R1), and diseases of the nervous system (R2). The longitudinal progression showed that APOE ε4 , amyloid, and tau were associated with R2 at early asymptomatic stages, but this longitudinal association occurs only at late symptomatic stages in R1. Our findings deepen our understanding of the multifaceted pathogenesis of AD beyond the brain. In early asymptomatic stages, the two dimensions are associated with diverse pathological mechanisms, including cardiovascular diseases, inflammation, and hormonal dysfunction—driven by genes different from APOE —which may collectively contribute to the early pathogenesis of AD. All results are publicly available at https://labs-laboratory.com/medicine/.

psychiatry
Multimodal Data Analysis of Alzheimer's Disease Based on Clustering Evolutionary Random Forest

Xia-an Bi,Xi Hu,Hao Wu,Yang Wang

DOI: https://doi.org/10.1109/jbhi.2020.2973324

IF: 7.7

2020-10-01

IEEE Journal of Biomedical and Health Informatics

Abstract:Alzheimer's disease (AD) has become a severe medical challenge. Advances in technologies produced high-dimensional data of different modalities including functional magnetic resonance imaging (fMRI) and single nucleotide polymorphism (SNP). Understanding the complex association patterns among these heterogeneous and complementary data is of benefit to the diagnosis and prevention of AD. In this paper, we apply the appropriate correlation analysis method to detect the relationships between brain regions and genes, and propose "brain region-gene pairs" as the multimodal features of the sample. In addition, we put forward a novel data analysis method from technology aspect, cluster evolutionary random forest (CERF), which is suitable for "brain region-gene pairs". The idea of clustering evolution is introduced to improve the generalization performance of random forest which is constructed by randomly selecting samples and sample features. Through hierarchical clustering of decision trees in random forest, the decision trees with higher similarity are clustered into one class, and the decision trees with the best performance are retained to enhance the diversity between decision trees. Furthermore, based on CERF, we integrate feature construction, feature selection and sample classification to find the optimal combination of different methods, and design a comprehensive diagnostic framework for AD. The framework is validated by the samples with both fMRI and SNP data from ADNI. The results show that we can effectively identify AD patients and discover some brain regions and genes associated with AD significantly based on this framework. These findings are conducive to the clinical treatment and prevention of AD.

computer science, interdisciplinary applications,mathematical & computational biology,medical informatics, information systems
Identifying Candidate Genetic Associations with MRI-Derived AD-Related ROI Via Tree-Guided Sparse Learning

Xiaoke Hao,Jintai Yu,Daoqiang Zhang

DOI: https://doi.org/10.1109/tcbb.2018.2833487

2018-01-01

IEEE/ACM Transactions on Computational Biology and Bioinformatics

Abstract:Imaging genetics has attracted significant interests in recent studies. Traditional work has focused on mass-univariate statistical approaches that identify important single nucleotide polymorphisms (SNPs) associated with quantitative traits (QTs) of brain structure or function. More recently, to address the problem of multiple comparison and weak detection, multivariate analysis methods such as the least absolute shrinkage and selection operator (Lasso) are often used to select the most relevant SNPs associated with QTs. However, one problem of Lasso, as well as many other feature selection methods for imaging genetics, is that some useful prior information, e.g., the hierarchical structure among SNPs, are rarely used for designing a more powerful model. In this paper, we propose to identify the associations between candidate genetic features (i.e., SNPs) and magnetic resonance imaging (MRI)-derived measures using a tree-guided sparse learning (TGSL) method. The advantage of our method is that it explicitly models the complex hierarchical structure among the SNPs in the objective function for feature selection. Specifically, motivated by the biological knowledge, the hierarchical structures involving gene groups and linkage disequilibrium (LD) blocks as well as individual SNPs are imposed as a tree-guided regularization term in our TGSL model. Experimental studies on simulation data and the Alzheimer's Disease Neuroimaging Initiative (ADNI) data show that our method not only achieves better predictions than competing methods on the MRI-derived measures of AD-related region of interests (ROIs) (i.e., hippocampus, parahippocampal gyrus, and precuneus), but also identifies sparse SNP patterns at the block level to better guide the biological interpretation.

Incorporation of radioactive orotic acid and 8-azaguanine into rat liver RNA.

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

Exploration of Imaging Genetic Biomarkers of Alzheimer's Disease Based on a Machine Learning Method

A Novel Longitudinal Phenotype-Genotype Association Study Based on Deep Feature Extraction and Hypergraph Models for Alzheimer's Disease

[Uterine rupture due to unrecognized uterine scarring].

Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer's Disease

Feature Detection Based on Imaging and Genetic Data Using Multi-Kernel Support Vector Machine–Apriori Model

Mining High-Level Imaging Genetic Associations via Clustering AD Candidate Variants with Similar Brain Association Patterns

Multi-Modal Data Analysis for Alzheimer’s Disease Diagnosis: An Ensemble Model Using Imagery and Genetic Features

Integrating omics and MRI data with kernel-based tests and CNNs to identify rare genetic markers for Alzheimer's disease

Integration of Imaging Genomics Data for the Study of Alzheimer's Disease Using Joint-Connectivity-Based Sparse Nonnegative Matrix Factorization

Deep Feature Selection and Causal Analysis of Alzheimer's Disease

Multi-modal imaging genetics data fusion by deep auto-encoder and self-representation network for Alzheimer's disease diagnosis and biomarkers extraction

Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease

A blueprint for hospitals in an aging society. Part 3: Creating the organizational backdrop for effective services.

Integrating Genetic Information for Early Alzheimer’s Diagnosis through MRI Interpretation

Detection of Association Features Based on Gene Eigenvalues and MRI Imaging Using Genetic Weighted Random Forest

Generalizable, Reproducible, and Neuroscientifically Interpretable Imaging Biomarkers for Alzheimer's Disease

Genetic and clinical correlates of two neuroanatomical AI dimensions in the Alzheimer's disease continuum

Multimodal Data Analysis of Alzheimer's Disease Based on Clustering Evolutionary Random Forest

Identifying Candidate Genetic Associations with MRI-Derived AD-Related ROI Via Tree-Guided Sparse Learning